117 related articles for article (PubMed ID: 29621097)
41. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
Ho DM; Hsu CY; Ting LT; Chiang H
Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
[TBL] [Abstract][Full Text] [Related]
42. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
[TBL] [Abstract][Full Text] [Related]
43. Comparative proteomic profiles of meningioma subtypes.
Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
[TBL] [Abstract][Full Text] [Related]
44. Malignant and atypical meningiomas: a reappraisal of clinical, histological, and computed tomographic features.
Alvarez F; Roda JM; Pérez Romero M; Morales C; Sarmiento MA; Blázquez MG
Neurosurgery; 1987 May; 20(5):688-94. PubMed ID: 3601014
[TBL] [Abstract][Full Text] [Related]
45. p53 and PCNA expression in benign, atypical and malignant meningiomas.
Ahmed R; Soomro IN; Aziz SA; Hasan SH
J Pak Med Assoc; 1999 Oct; 49(10):241-3. PubMed ID: 10647228
[TBL] [Abstract][Full Text] [Related]
46. Lipid signal in evaluation of intracranial meningiomas.
Qi ZG; Li YX; Wang Y; Geng DY; Li KC; Shen TZ; Chen XR
Chin Med J (Engl); 2008 Dec; 121(23):2415-9. PubMed ID: 19102960
[TBL] [Abstract][Full Text] [Related]
47. Characterization of pituitary tumor transforming gene in meningiomas.
Zhang H; Du R; Huang YH; She L; Dong L; Wang X; Kwan AL
Clin Neurol Neurosurg; 2014 Jul; 122():120-3. PubMed ID: 24908230
[TBL] [Abstract][Full Text] [Related]
48. Pathodiagnostic parameters for meningioma grading.
Moradi A; Semnani V; Djam H; Tajodini A; Zali AR; Ghaemi K; Nikzad N; Madani-Civi M
J Clin Neurosci; 2008 Dec; 15(12):1370-5. PubMed ID: 18819804
[TBL] [Abstract][Full Text] [Related]
49. Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature.
Vaubel RA; Chen SG; Raleigh DR; Link MJ; Chicoine MR; Barani I; Jenkins SM; Aleff PA; Rodriguez FJ; Burger PC; Dahiya S; Perry A; Giannini C
J Neuropathol Exp Neurol; 2016 Jan; 75(1):44-52. PubMed ID: 26705409
[TBL] [Abstract][Full Text] [Related]
50. Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma.
Smith JS; Lal A; Harmon-Smith M; Bollen AW; McDermott MW
J Neurosurg; 2007 Jun; 106(6):1034-40. PubMed ID: 17564176
[TBL] [Abstract][Full Text] [Related]
51. MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas.
Winther TL; Torp SH
J Neurooncol; 2017 Feb; 131(3):575-583. PubMed ID: 27868157
[TBL] [Abstract][Full Text] [Related]
52. A study of UbcH10 expression and its association with recurrence of meningiomas.
Jiang L; Wang T; Bao Y; Qian J; Wu XJ; Hu GH; Lu YC
J Surg Oncol; 2012 Sep; 106(3):327-31. PubMed ID: 22095464
[TBL] [Abstract][Full Text] [Related]
53. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
[TBL] [Abstract][Full Text] [Related]
54. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
[TBL] [Abstract][Full Text] [Related]
55. Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen.
Pizem J; Velnar T; Prestor B; Mlakar J; Popovic M
Clin Neuropathol; 2014; 33(5):354-63. PubMed ID: 25034703
[TBL] [Abstract][Full Text] [Related]
56. Differential Diagnosis of Meningeal SFT-HPC and Meningioma: Which Immunohistochemical Markers Should Be Used?
Macagno N; Figarella-Branger D; Mokthari K; Metellus P; Jouvet A; Vasiljevic A; Loundou A; Bouvier C
Am J Surg Pathol; 2016 Feb; 40(2):270-8. PubMed ID: 26448189
[TBL] [Abstract][Full Text] [Related]
57. High throughput screening of meningioma biomarkers using a tissue microarray.
Lusis EA; Chicoine MR; Perry A
J Neurooncol; 2005 Jul; 73(3):219-23. PubMed ID: 15980972
[TBL] [Abstract][Full Text] [Related]
58. [P53 protein expression and proliferative potential in non-recurrent and recurrent meningiomas].
Miyagami M; Kanou T; Nakamura S
No To Shinkei; 1996 Aug; 48(8):719-25. PubMed ID: 8797205
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of STMN1 is associated with the prognosis of meningioma patients.
Wang H; Li W; Wang G; Zhang S; Bie L
Neurosci Lett; 2017 Jul; 654():1-5. PubMed ID: 28625575
[TBL] [Abstract][Full Text] [Related]
60. 13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report.
Xiangsong Z; Xingchong S; Chang Y; Xiaoyan W; Zhifeng C
Clin Nucl Med; 2011 Nov; 36(11):1003-6. PubMed ID: 21975388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
